Ó³»­´«Ã½

This two-day in-person symposium on September 16 and 17, 2025, will be chaired by Dr. Steve Hyman, director of the Program in Brain Health at Ó³»­´«Ã½, Dr. Zhanyan Fu of the Stanley Center at Ó³»­´«Ã½, Dr. Evan Macosko of the Stanley Center at the Ó³»­´«Ã½ and Harvard Medical School, and Dr. Elise Robinson of Massachusetts General Hospital and associate director of Human Genetics at the Stanley Center. It will bring together scientists working on the frontiers of genetics, neurobiology, computational psychiatry, and therapeutic development for schizophrenia, bipolar disorder, and related neuropsychiatric disorders.

The central theme of this symposium revolves around addressing the challenges of turning human genetics findings for severe mental illnesses into biology that will inform and drive the identification of biomarkers and novel therapeutics. In this symposium, speakers will present important new findings that will have an impact on neuropsychiatric research. The program will include keynote speeches from David Altshuler, EVP and CSO of Vertex and Belinda Lennox, Head of the Department of Psychiatry, University of Oxford along with a wide range of other talks, panels, and a poster session. 

Full agenda and registration link coming soon.